Lawmakers Co-Sponsor Legislation to Support the National Breast Cancer Coalition’s Deadline 2020
DOVER, DE (October 28, 2015)— The Delaware Breast Cancer Coalition (DBCC) is pleased to announce that Congressman John Carney, Senator Tom Carper, and Senator Chris Coons have declared their support as Co-Sponsors for the Accelerating the End of Breast Cancer Act (S. 746/ H.R. 1197). The Accelerating the End of Breast Cancer Act is a bipartisan bill that will focus on identifying strategies for primary prevention, stopping women and men from getting breast cancer, and understanding and preventing metastasis—the spread of cancer—which is responsible for 90% of breast cancer deaths.
The Deadline Breast Cancer Coalition supports the National Breast Cancer Coalition’s advocacy efforts to know how to end Breast Cancer by January 1, 2020. Through research, access and influence, the National Breast Cancer Coalition’s efforts are both ambitious and achievable.
“More than 750 Delawareans will be diagnosed with breast cancer this year, and thousands more across the country will lose their battle with this deadly disease,” Senator Coons said. “Innovative research has transformed breast cancer diagnosis and treatment, but breast cancer rates have continued to rise, and women today face a greater risk of contracting the disease than they did four decades ago. It’s time to scale up our efforts to combat this disease, so we can move closer to our goal of eliminating breast cancer by 2020. It is clear that ending breast cancer is beyond a political issue. It is up to the leaders of this nation to work together to support the Accelerating the End of Breast Cancer Act so we can end morbidity and mortality due to this disease.”
According to the Delaware Breast Cancer Coalition’s Executive Director Vicky Cooke, the Accelerating the End of Breast Cancer Act is one major step needed to achieve the Deadline. “I am a breast cancer survivor and I am a proud mother and grandmother. I support Deadline 2020 so my children and my grandchildren won’t have to face breast cancer and we can stop losing our loved ones to this horrific disease. I don’t want to cure it, because a cure implies you have to get it. I want to end it. And in Delaware, we are proud and grateful to have one hundred percent support from our Congressional leaders.”
To learn more about Deadline 2020 or the National Breast Cancer Coalition, visit http://www.breastcancerdeadline2020.org.
The Delaware Breast Cancer Coalition is a 501(c)(3) organization offering statewide programs and services of education, outreach, and early detection and treatment of breast cancer. Its mission is to create a community where every person diagnosed with breast cancer is a survivor, and fear and doubt are replaced with knowledge and hope.
Headquartered in Wilmington with offices in Sussex and Kent Counties, DBCC’s programs reach diverse communities to deliver messages that address their unique concerns about breast cancer and early detection. Recognizing the barriers of language, culture, and economics, DBCC trains community advocates to educate and encourage women to take responsibility for breast health. DBCC helps women with low incomes and those with little or no insurance to receive free or reduced-cost care.
DBCC also supports the National Breast Cancer Coalition and their research efforts by helping to facilitate participation in local clinical trials. All funds raised for DBCC support programs in Delaware and the neighboring areas in Pennsylvania, Maryland, and New Jersey.
For more information about the Delaware Breast Cancer Coalition, call 866-312-DBCC (3222) or visit the website at www.debreastcancer.org.